14 results
8-K
EX-10.2
SHPH
Shuttle Pharmaceuticals Holdings Inc
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
in connection with BSL’s engagement are intended solely for the benefit and use of the Company in considering the transaction to which they relate … and agreed by the parties hereto that all other terms and conditions of that certain engagement letter between the Company and BSL dated as of November 10
8-K
EX-10.1
SHPH
Shuttle Pharmaceuticals Holdings Inc
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
engagement by Company to Company provided such obligation to assign does not conflict with any obligation to assign such inventions to Georgetown … , and interest in any invention(s) made in the course of their employment or other engagement to Georgetown.
“Infringe,” “Infringement”, or any correlative
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
24 Aug 23
Prospectus supplement
2:00pm
for both clinical studies and commercial sales.
Engagement of Theradex Oncology
In November 2022, Shuttle announced it had engaged Theradex Oncology
S-1
EX-10.28
yjyec29ln8nw1b
3 Jun 22
IPO registration
5:32pm
S-1
EX-10.31
7u7o7l
3 Jun 22
IPO registration
5:32pm
S-1
EX-10.25
9g724pfqc c5i4noij
3 Jun 22
IPO registration
5:32pm
DRS
0fkh6e2
16 Sep 19
Draft registration statement
12:00am
- Prev
- 1
- Next